Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
CONTEXT: Combined infusion of levothyroxine plus liothyronine, as opposed to levothyroxine alone, is the only way of restoring the concentrations of circulating TSH, T4, and T3 as well as those of both T4 and T3 in all tissues of thyroidectomized rats. Considering the substantial differences in thyroid hormone secretion, transport, and metabolism between rats and humans, whether or not combined levothyroxine plus liothyronine replacement therapy has advantages over treatment with levothyroxine alone in hypothyroid patients is still questioned. EVIDENCE ACQUISITION: We conducted a systematic review of all the published controlled studies comparing treatment with levothyroxine alone with combinations of levothyroxine plus liothyronine in hypothyroid patients, identified through the Entrez-PubMed search engine. EVIDENCE SYNTHESIS: Nine controlled clinical trials were identified that compared treatment with levothyroxine alone and treatment with combinations of levothyroxine plus liothyronine and included a sufficient number of adult hypothyroid patients to yield meaningful results. In only one study did the combined therapy appear to have beneficial effects on the mood, quality of life, and psychometric performance of the patients over levothyroxine alone. These results have not been confirmed by later studies using either T3 substitution protocols or approaches with fixed combinations of levothyroxine plus liothyronine, including those based on the physiological proportion in which T3 and T4 are secreted by the human thyroid. However, in some of these studies the patients preferred levothyroxine plus liothyronine combinations, for reasons not explained by changes in the psychological and psychometric tests employed. Yet patients' preference should be balanced against the possibility of adverse events resulting from the addition of liothyronine to levothyroxine, even in the small doses used in these studies. CONCLUSIONS: Until clear advantages of levothyroxine plus liothyronine are demonstrated, the administration of levothyroxine alone should remain the treatment of choice for replacement therapy of hypothyroidism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, systematic reviews and metaanalyses of 18 trials of combination levothyroxine-liothyronine replacement found no clear benefit over levothyroxine monotherapy.12,13”
From Hypothyroidism (2024) · cites this paper as [13]
In the citing paper
“Furthermore, four systematic reviews and metaanalyses 12,13,180,181 of these trials found no clear benefit of combination levothyroxineliothyronine therapy over levothyroxine monotherapy in terms of mood, healthrelated quality of life, or cognitive function.”
From Hypothyroidism (2024) · cites this paper as [13]
In the citing paper
“This combined therapy aims to more closely mimic the natural secretion of the thyroid gland, potentially restoring physiological levels of T3 and T4 across various tissues [28].”
In the citing paper
“This may constitute a bias, as the benefit of combination therapy in one trial was observed only in the thyroid cancer patients and not in patients with autoimmune thyroiditis [48,49] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [49]
In the citing paper
“Indeed, serum free T4 to free T3 ratios in patients randomized to receive L-T4 monotherapy range from 4.0 to 5.5 ( table 3 ), higher than the value of 3.3 observed in healthy controls [49] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [49]
Citations
Cites
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Ingbar, S. H. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870060154035 · Cited by 1,743
Baskin, H. J., Cobin, R. H., Duick, D. S., Gharib, H., Guttler, R. B., Kaplan, M. M., Segal, R. L., Garber, J. R., Hamilton Jr, C. R., Handelsman, Y., et al. (2002) · Endocrine Practice · doi:10.4158/1934-2403-8.6.457 · Cited by 673
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 2×
“(30, 32) was greeted with considerable interest not only for scientific reasons but also for hypothyroid patients; combined levothyroxine plus liothyronine replacement was considered the answer to the relatively frequent complaint (35) of the persistence, with levothyroxine alone, of hypothyroid symptoms despite norma…”
BackgroundBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 7×
“(30, 32), it would appear that T3 substitution has a minor role, if any, in thyroid replacement therapy (14, 31, 41).”
BackgroundMethodResultInfluentialAdvances in Our Understanding of Thyroid Hormone Action at the Cellular Level*
OPPENHEIMER, J. H., SCHWARTZ, H. L., MARIASH, C. N., KINLAW, W. B., WONG, N. C. W., & FREAKE, H. C. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-3-288 · Cited by 476
Bianco, A. C. (2002) · Endocrine Reviews · doi:10.1210/er.23.1.38 · Cited by 423
Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Self-citation
Cited by
Items 101–161 of 161
Thyroid hormone replacement: an iatrogenic problem
O’Reilly, D. S. J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02317.x · Cited by 4
Congenital Hypothyroidism—Monitoring Thyroid Function in Infants
Straussman, S., Levitsky, L. L., & Endocrinology, F. I. P. (2011) · US Endocrinology · doi:10.17925/use.2011.07.02.126 · Cited by 4
Clinical Practice Recommendations for Assessment and Management of Hypothyroidism
Alsifri, S. N., Aljuhani, N. R., Al-Jedai, A. H., Nasser, T., Alsabaan, F., Almudaiheem, H., Amir, A., Baissa, E., Ghannam, N., Aldawish, M., et al. (2022) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2022.1312046 · Cited by 4
Low Triiodothyronine Syndrome and Depression in Patients with Chronic Heart Failure
Bunevičius, R. (2009) · Springer eBooks · doi:10.1007/978-88-470-1143-4_18 · Cited by 5
Eligar, V. S., Taylor, P. N., Okosieme, O. E., & Dayan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00077-8 · Cited by 3
Primary Hypothyroidism: New Issues and Controversies
Surks, M. I. (2006) · The Endocrinologist · doi:10.1097/01.ten.0000225121.32244.a7 · Cited by 3
Azizi, F., Amouzegar, A., Abdi, H., Tohidi, M., Masoumi, S., Khalili, D., Mehrabi, Y., Zadeh–Vakili, A., Hedayati, M., Momenan, A. A., et al. (2025) · Trials · doi:10.1186/s13063-025-08940-5 · Cited by 3
“Double-blind, randomized control clinical trial.”
McDermott, M., & Ridgway, E. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-5 · Cited by 4
Wass, J. A. H., Owen, K. R., & Turner, H. E. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199644438.003.0001 · Cited by 2
Aspects of diagnosis and treatment of hypopituitarism in adult life
Nyström, H. F. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
T3 and T4: Are we missing half the picture?
Klein, I. L. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80051-1 · Cited by 3
Hypothyroid symptoms following radioiodine therapy for graves' disease
Anolik, J. R. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80056-0 · Cited by 1
Terapia sostitutiva combinata con L-T4 e L-T3 nell’ipotiroidismo
Biondi, B., Celi, F. S., Duntas, L. H., Isidori, A. M., Pontecorvi, A., Salvatore, D., Vitti, P., & Trimarchi, F. (2015) · L Endocrinologo · doi:10.1007/s40619-015-0158-6 · Cited by 1
“[24–27].”
Wilson’s Syndrome (Low T3 Syndrome)
Tang, C. J., & Garber, J. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_21 · Cited by 1
Kim, M. J., & Ladenson, P. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00560-1 · Cited by 2
Azizi, F., Moeini, A. S. H., Mehran, L., Masoumi, S., Abdi, H., Foroutan, S. M., Saghafinia, A. E., & Amouzegar, A. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100395 · Cited by 4
“One systematic review [32] and one meta -analysis [18] showed that fatigue, mood, anxiety, depression, and quality of life were not better in the LT3/LT4 group than in the LT4 group.”
Bailey, S., & McCaffery, P. J. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_5 · Cited by 2
Evaluation of sub-clinical thyroid disease in adult patients
Alam, J. M., Baig, J. A., Sultana, I., Baig, M., Mahmood, S. R., & Ahmad, A. (2010) · Cited by 2
Substitution mit Schilddrüsenhormonen im höheren Lebensalter: Ziele und Gefahren
von Werder, A., & von Werder, K. (2018) · Der Internist · doi:10.1007/s00108-018-0458-6 · Cited by 2
Temple, L. M., & Saigal, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00034-7 · Cited by 1
Monitoring Levothyroxine Replacement in Primary Hypothyroidism
Horvath, A. R. (2008) · Wiley eBooks · doi:10.1002/9780470696323.ch19 · Cited by 1
Als, C., Pescatore, P., Jacqué, M., & Faber, C. (2011) · Médecine Nucléaire · doi:10.1016/j.mednuc.2011.07.006 · Cited by 1
Davis, P. J., Davis, F. B., & Leinung, M. C. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2261-9.50048-3 · Cited by 1
Toft, A. D. (2011) · doi:10.1093/med/9780199235292.003.3293 · Cited by 1
Endocrine Disorders: Medical Management
Oliver, N. S., & Robinson, S. (2010) · Wiley eBooks · doi:10.1002/9781444307641.ch6
Temple, L. M. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50037-3
Relevanz von Schilddrüsenhormonen als Screeninginstrument für postpartale Depression
Große, H. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10533
Combination therapy in a hypothyroid patient intolerant of elevated thyroxine
Singer, A. J. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80054-7
T4 versus T3 and T4: Is It a Real Controversy?
Weetman, A. P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097569
Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose?
Piantanida, E., Compri, E., Gandolfo, M., Sassi, L., Dionigi, G., Lai, A., Tanda, M. L., & Bartalena, L. (2009) · Current Cancer Therapy Reviews · doi:10.2174/157339409789712717
“A number of subsequent studies, summarized in three recent meta-analysis [29, 45, 46], failed to demonstrate any clear advantage of the combination therapy over L-T4 alone; in some instances patients preferred the combination therapy, possibly because they became slightly thyrotoxic due to the addition of L-T3 [47].”
BackgroundResultAlternative Delivery Approaches for Levothyroxine (T4)
Anand, U., Agu, R. U., & Imran, S. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.074
Treatment of Hypothyroidism: Utility of Adding T3 (Liothyronine)
Tsai, J. N., & Stathatos, N. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_11
Baron, H. L., & SINGER, P. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50042-1 · Cited by 2
Albanese, N. P. (2009) · The American Pharmacists Association eBooks · doi:10.21019/9781582121055.ch27
Kant, R., & Verma, V. K. (2018) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000e127
“In some of these studies patients preferred combination LT4/LT3 even though no or minimal statistically significant differences were observed in primary outcomes [6-19].”
BackgroundSubstitution mit Schilddrüsenhormonen: Seien Sie bei Älteren zurückhaltend
von Werder, A., & von Werder, K. (2019) · Geriatrie-Report · doi:10.1007/s42090-019-0222-7
Sakr, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-48775-1_2 · Cited by 1
NHG-Standaard Schildklieraandoeningen: Eerste herziening
Wessels, P., van Rijswijk, E., Boer, A., & van Lieshout, J. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_71
T3 therapy for hypothyroidism: choosing wisely still requires careful bench to bedside translation
Dora, J. M., Scheffel, R. S., & Maia, A. L. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000377
“A systematic review that included 9 randomized trials reported beneficial effects of combination LT4 + LT3 therapy only in one trial (6).”
BackgroundChavez, C. P., & Ospina, N. S. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.346-349
Newman, S. K., & Davies, T. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00120-1 · Cited by 1
Luíz, H. V., Manita, I., & Portugal, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_7
Thomas, M. J., & Brown, S. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4417-8.50048-6
(2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0738-6.00011-5
Temple, L. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00033-9 · Cited by 1
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000244230.06529.0f
(2019) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-9655-4.ch014
Annamalai, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-51026-2_13
Temple, L. M. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50041-7 · Cited by 1
Pombo, J. L. H. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73180-1 · Cited by 4
Ceylan, Ş., & Yilmaz, N. (2023) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405619666230209123957 · Cited by 1
Bestaat er een indicatie voor T3-suppletie?
Beukhof, J. R., & Jansman, F. G. A. (2006) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8808-0_1312
Zhang, X., & Lee, V. C. S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004546
Impact of Thyroid Cancer on Behavior and Psychology
Vainer, I., & Yaniv, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-32046-0_109-1
Impact of Thyroid Cancer on Behavior and Psychology
Vainer, I., & Yaniv, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_109
Nassar, M., Hassan, A., Ramadan, S., Desouki, M., Hassan, M. A., & Chaudhuri, A. (2024) · Figshare · doi:10.6084/m9.figshare.26733783
Chandrupatla, S. R., Rumalla, K. C., & Singh, J. A. (2026) · Journal of Experimental Orthopaedics · doi:10.1002/jeo2.70413
“Hypothyroidism is a common condition [17, 23], with a prevalence between 0.3% and 3.7% in the United States depending on the population studied and de fi nition used [9].”
InfluentialYuan, A., Yan, Z., Wu, J., Song, Y., & Huang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1776734
Chronic Thyroiditis: Hashimoto’s Disease
Sakr, M. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-19513-5_9
Imam, S. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-12937-6_11 · Cited by 1
Metadata
- Authors
- Escobar-Morreale, H. F., Botella-Carretero, J. I., del Rey, F. E., & de Escobar, G. M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-08
- Volume
- 90
- Issue
- 8
- Pages
- 4946-4954
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2081588773
- Cited by
- 160
- References
- 49
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 10 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 8 · 2013: 5 · 2012: 12
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Comunidad de Madrid
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- hypothyroidism, levothyroxine, liothyronine, T4/T3 ratio, thyroid hormone replacement, quality of life, mood, psychometric performance, patient preferences, adverse events
- MeSH terms
- Drug Therapy, Combination, Humans, Hypothyroidism, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.